Inhibitory effect of polar oregano extracts on aldose reductase and soybean lipoxygenase in vitro

Phytotherapy Research

Volumn 20, Issue 7, 2006, Pages 605-606

  Koukoulitsa, Catherine ^a   Zika, Chariklia ^b   Hadjipavlou Litina, Dimitra ^b   Demopoulos, Vassilis J ^b   Skaltsa, Helen ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Aldose reductase; Origanum vulgare L. ssp. hirtum; Soybean lipoxygenase

Indexed keywords

ALDEHYDE REDUCTASE; LIPOXYGENASE; METHANOL EXTRACTION RESIDUE; ORIGANUM VULGARE EXTRACT; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG INHIBITION; IN VITRO STUDY; NONHUMAN; OREGANO; SOYBEAN;

ALDEHYDE REDUCTASE; LIPOXYGENASE; LIPOXYGENASE INHIBITORS; METHANOL; ORIGANUM; PLANT EXTRACTS; PLANT PROTEINS; SOYBEANS;

GLYCINE MAX; ORIGANUM VULGARE;

EID: 33746001481     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1901     Document Type: Article

References (5)

1. Ietswaart JH. 1980. A taxonomic revision of the genus Origanum (Labiatae), PhD thesis. Leiden Botanical Series. Leiden University Press: The Hague, 4, 106.
2. Kontogiorgis C, Hadjipavlou-Litina D. 2003. Biological evaluation of several coumarin derivatives designed as possible anti-inflammatory/antioxidant agents. J Enzyme Inhib Med Chem 18: 63-69.
3. Koukoulitsa C, Zika C, Geromichalos GD, Demopoulos VJ, Skaltsa H. 2005. Evaluation of aldose reductase inhibition and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum. Bioorg Med Chem 14: 1653-1659.
4. Miyamoto S. 2002. Recent advances in aldose reductase inhibitors: potential agents for the treatment of diabetic complications. Expert Opinion 12: 621-631.
5. Pontiki E, Hadjipavlou-Litina D. 2003. Review in quantitative structure activity relationships on lipoxygenase inhibitors. Mini Rev Med Chem 3: 487-499.